Cas:73799-63-0 3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione manufacturer & supplier

Chemical Name:3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione

CAS.NO:73799-63-0

Synonyms:3-(benzyl)-3-azabicyclo(3.1.0)hexan-2,4-dione;3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione;3-Benzyl-3-azabicyclo(3.1.0)hexane-2,4-dione;3-Azabicyclo[3.1.0]hexane-2,4-dione, 3-(phenylmethyl)-;N-benzyl azabicyclohexane-2,4-dione;benzylazabicyclohexanedione

Molecular Formula:C₁₂H₁₁NO₂

Molecular Weight:201.221

HS Code:2925190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:416.3±24.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.642

PSA:37.38000

Exact Mass:201.078979

LogP:0.68

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(benzyl)-3-azabicyclo(3.1.0)hexan-2,4-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,benzylazabicyclohexanedione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione Use and application,3-Benzyl-3-azabicyclo(3.1.0)hexane-2,4-dione technical grade,usp/ep/jp grade.

Related News: In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione manufacturer As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione supplier In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione vendor In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione factory The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA.